EE: Ethinyl estradiol; LNG: Levonorgestrel; OC: Oral contraceptive; RR: Relative risk; VTE: Venous thromboembolism. Transdermal contraceptive patches provide a more convenient delivery system for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Blood clot risk elevated with contraceptive patches, vaginal rings Women who use the combined contraceptive transdermal patch or vaginal ring are at significantly higher risk for venous thrombosis, ...

The new labeling for the patch will include information about the higher levels of estrogen.The Ortho Evra contraceptive patch, produced by Ortho McNeil Pharmaceuticals, a unit of Johnson & Johnson ...

WASHINGTON -- Federal health officials approved sale of the world's first contraceptive patch yesterday, giving women an option considered as safe and effective as the pill but easier for some to use.

WASHINGTON -- American women may soon buy the world's first birth control in a skin patch. The Food and Drug Administration approved Ortho-Evra on Tuesday, a patch that prevents pregnancy by emitting ...

The patch supplies norelgestromin and ethinyl estradiol to the bloodstream through the skin. Has any evidence of genital swelling been documented with the use of the patch when placed inappropriately?

NEW YORK (Reuters Health) - Women who use a contraceptive patch appear to be more than twice as likely to develop a dangerous blood clot in their veins as those who use an oral contraceptive, new ...

Johnson & Johnson has adopted a quick-settlement strategy for a spate of suits charging that its Ortho Evra contraceptive patch causes blood clots due to heightened estrogen levels. Some suits have ...

PITTSBURGH, July 29, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved Gwyn Lo™ ...